In conclusion, we have shown that patients with sepsis have different serum concentrations of SEMA3A, SEMA3C, SEMA3F, SEMA4D, and SEMA7A compared to healthy controls and that their kinetics during sepsis correlate with disease severity and outcomes. This evidence concerns the gene SEMA7A and Sepsis.